CVIR Endovascular

What CVIR Endovascular does

CVIR Endovascular is a peer-reviewed, multidisciplinary open access academic journal dedicated to endovascular interventions. Founded in 2015 and operated by an 8-person team based in Vienna, Austria, the journal is published by Springer Nature through SpringerOpen and serves as one of three official journals of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), alongside CVIR Online and CVIR Oncology. Its primary audience consists of interventional radiologists, endovascular specialists, CIRSE members, and medical researchers, with secondary engagement from junior interventional radiologists progressing through the Reviewer Forum toward editorial board membership.

The journal's product surface extends beyond the core article publication on the SpringerOpen platform to include the "Speaking of Endovascular Interventions" blog, an Author Spotlight video series, a Quarterly Update newsletter with trivia quizzes, a podcast, visual abstracts as a submission feature, and promotion of the EBIR-ES specialist certification pathway. The underlying technology stack is built on Jimdo (CMS for the reader-facing site), SpringerOpen (article hosting and discovery), and Editorial Manager (peer-review workflow). The journal reports a 2.1 impact factor (2025, 2-year), 1.5 (5-year), 498.1k annual downloads in 2025, and an 11-day median time to first decision.

Revenue is generated through Article Processing Charges (APCs) paid by authors, with costs frequently subsidized by institutional agreements brokered via Springer Nature. The journal does not charge readers. Marketing and community-building are channeled primarily through CIRSE's society infrastructure and annual conferences, supplemented by an active presence on Facebook, Twitter/X, LinkedIn, and YouTube. Current editorial leadership comprises Prof. Robert Morgan (Editor-in-Chief), Prof. Jim Reekers (Emeritus Editor-in-Chief), and Sara Lojo (Social Media Editor).

Name

CVIR Endovascular

Legal name

CVIR Endovascular

Website

https://cvirendovascular.org

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

CVIR Endovascular is an official CIRSE-published, peer-reviewed open access journal dedicated to endovascular interventions, serving interventional radiologists and endovascular specialists globally with rapid peer review and multimedia community content.

Ownership category

akta.pro rank

Product category

Medical Journal Publishing

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

akta.pro industry

PRIMARYEDAGANAJ

Healthcare & Clinical Professional Development (CME/CE)

Education/Educational Publishing & Learning Content/Professional Development & Training Materials

Keywords

• Academic journal publishing
• Endovascular interventions
• Open access publishing
• Interventional radiology
• Medical research publishing

Headquarters

HQ city

Online/Headquarters location not explicitly stated

Offices1 record

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Operations, Technology or R&D, Others

Revenue model

1. Article Processing Charges (APC): Authors pay article processing charges to publish open access. Springer Nature has made several agreements for fully open access journals providing financial support for APC costs. Only certain article types are covered in these agreements, and the corresponding author must have institutional access.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

CVIR Endovascular is a peer-reviewed, multidisciplinary open access journal dedicated to endovascular interventions. It is the official journal of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) and is published by SpringerOpen. The journal disseminates original research, reviews, case reports, and clinical studies on endovascular and interventional radiology topics to a global medical audience.

Product overview

CVIR Endovascular is a single, unified open access journal product published by CIRSE (Cardiovascular and Interventional Radiological Society of Europe) through SpringerOpen. The journal is accompanied by complementary content features including a blog ("Speaking of Endovascular Interventions"), an Author Spotlight video series, a Quarterly Update newsletter, and a Podcast. Authors can submit visual abstracts alongside manuscripts, and the journal supports specialist certification pathways (EBIR-ES) through its parent organization CIRSE. All content is fully open access.

Differentiator

Problem solved

Functional benefit

Products and services

• CVIR Endovascular Journal A peer-reviewed, multidisciplinary open access academic journal publishing original research, reviews, case reports, and clinical studies on endovascular and interventional radiology. It serves physicians, researchers, and clinicians in the field of endovascular intervention.

Quantifiable outcome

• 2.1 impact factor (2025, 2-year); 1.5 impact factor (5-year)
• +2 more outcomes

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Cardiovascular and Interventional Radiological Society of Europe (CIRSE)coreStrategic or Co-development PartnerCIRSE is the parent society of CVIR Endovascular. CIRSE is a multidisciplinary society dedicated to advancing interventional radiology through education, research, and professional development. CVIR Endovascular is one of three journals in the CIRSE Journal Family (alongside CVIR Online and CVIR Oncology). CIRSE provides editorial oversight, reviewer networks, SOP documents, EBIR certification, and annual conference infrastructure that together form the ecosystem supporting the journal.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Springer Nature: The publisher of CVIR Endovascular via SpringerOpen, and a broader incumbent in scientific, technical, and medical publishing. Comparable as the publishing platform and distribution infrastructure the journal depends on.
• Elsevier (Vascular Surgery journals portfolio): A major scientific publisher operating competing vascular and endovascular journals (e.g., Journal of Vascular Surgery). Comparable as a large, established incumbent in the same publishing market with overlapping journal portfolio.
• Journal of Vascular Surgery: Premier journal of the Society for Vascular Surgery covering the full spectrum of vascular and endovascular surgery. A larger, established incumbent with higher impact factor and broader scope, but a long-standing destination for endovascular submissions.

Direct peers

• Endovascular Today: Trade publication and clinical resource for the endovascular specialist community. Competes for the attention and content contributions of the same endovascular practitioner audience.
• Annals of Vascular Surgery: Peer-reviewed journal publishing clinical research across vascular and endovascular surgery. Direct competitor for endovascular clinical manuscripts from vascular surgeons and interventionalists.
• European Journal of Vascular and Endovascular Surgery: Official journal of the European Society for Vascular Surgery, covering endovascular and vascular surgery research. Competes head-to-head with CVIR Endovascular for clinical endovascular submissions in the European market.
• CVIR Oncology: A third CIRSE family journal focused on interventional oncology. Sister publication sharing the same publisher (Springer Nature), peer-review infrastructure, and society backing as CVIR Endovascular.
• Cardiovascular and Interventional Radiology (CVIR): The flagship sister journal of CVIR Endovascular within the CIRSE family. Overlaps substantially on endovascular content and competes with the same author base of interventional radiologists.
• Journal of Endovascular Therapy: A peer-reviewed journal dedicated to endovascular interventions and minimally invasive vascular therapy. Directly competes with CVIR Endovascular for the same author pool of vascular interventionalists and endovascular specialists.

Emerging players

• Vascular (Sage journal): Official journal of the International Society of Vascular Surgery, covering vascular and endovascular research. A peer-reviewed competitor at a similar scale and stage of development to CVIR Endovascular.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/cvirendo
• YouTubeyoutube.com/user/CIRSEsociety
• Facebookfacebook.com/CVIR-Endovascular-CIRSEs-open-access-journal-114264623277183
• LinkedInlinkedin.com/company/cvir-endovascular

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CVIR Endovascular